Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
Cytori Therapeutics Inc. (CYTX) unveiled a pact to commercialize the company's cell therapies for the cardiovascular, renal and diabetes markets in Australia and several Asian nations. Shares of Cytori soared 46% to $3.05 after hours, after the company said partner Lorem Vascular will pay up to $500 million in fees for a 30-year exclusive license to Cytori. http://bigcharts.marketwatch.com/quickchart/quickchart.asp?s...
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement